Related Experiment Video
Updated: Sep 7, 2025
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.4K
NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022
William G Wierda1, Jennifer Brown2, Jeremy S Abramson3
1The University of Texas MD Anderson Cancer Center.
Summary
New targeted therapies offer chemotherapy-free options for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Achieving undetectable minimal residual disease predicts better survival in patients on fixed-duration BCL-2 inhibitor treatment.
Area of Science:
- Hematology
- Oncology
- Clinical Guidelines
Background:
- The treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) has shifted towards targeted therapies.
- Bruton's tyrosine kinase (BTK) inhibitors and BCL-2 inhibitors provide effective chemotherapy-free treatment options.
Purpose of the Study:
- To discuss updates to the NCCN Guidelines for CLL/SLL.
- Focus on chemotherapy-free treatment strategies for both treatment-naïve and relapsed/refractory CLL/SLL patients.
Main Methods:
- Review of recent clinical advancements in CLL/SLL treatment.
- Analysis of NCCN Guidelines pertaining to targeted therapies.
- Evaluation of minimal residual disease (MRD) as a prognostic marker.
Main Results:
- Targeted therapies (BTK and BCL-2 inhibitors) are now standard chemotherapy-free options.
- Undetectable MRD post-treatment is a significant predictor of progression-free and overall survival.
- NCCN Guidelines have been updated to reflect these changes.
Conclusions:
- Chemotherapy-free targeted treatments represent a major advancement in CLL/SLL management.
- Monitoring for undetectable MRD is crucial for assessing treatment efficacy and patient outcomes.
- Updated NCCN Guidelines support the integration of these novel approaches.
More Related Videos
Related Concept Videos
01:16Primary Lymphoid Organs
5.7K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
5.7K
01:18Lymphoid Cells and Tissues
1.5K
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
1.5K
01:15Secondary Lymphoid Organs
3.1K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
3.1K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K